This is unpublished
Currently Enrolling
Patients with Inflammatory arthritis from cancer therapy (immune checkpoint inhibitor)
- Enrolling patients more than 18 years old with inflammation in their joints
- Patients should not be on medications that suppress the immune system (like steroids, biologics) within the past 3 months
- Please let your rheumatologist know if you are interested in participating
Patients with rheumatoid arthritis and cancer
- Enrolling patients more 18 years old with rheumatoid arthritis and cancer
- Please let your rheumatologist know if you are interested in participating
Pediatric patients transitioning to adult care
- Enrolling patients 16-23 with childhood onset rheumatic disease transitioning to adult care at UW rheumatology
- Patients are asked to fill out a five minute survey at the start of the study and again one year later
- Please let your rheumatologist know if you are interested in participating
Systemic Lupus Erythematosus
- Enrolling patients 18 and above with lupus who have not had severe lupus nephritis and are on 20 mg or less of prednisone
- Patients should have active lupus without hair loss, fever, headache
Biorepository
- Enrolling patients 18 and above with sjogren’s, rheumatoid arthritis or lupus
- Patients are asked to donate blood for basic science studies when they see their rheumatologist
- Please let your rheumatologist know if you are interested in participating
Upcoming Study Areas
Stay tuned for more information on upcoming studies for Systemic Lupus Erythematosus, Rheumatoid Arthritis, Giant Cell Arteritis, Lupus Nephritis, Psoriatic Arthritis and Scleroderma.
Contact Us
Connect with the team via email or call to speak with our Research Manager.
Email: RheumResearch@medicine.washington.edu
Phone: 206-616-5330
If you have questions, are interested in participating, or want to sponsor a study at our site, let us know!